Bartosz Bielecki

Dr. Bartosz Bielecki

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MTMałgorzata Turniak-Kusy
Małgorzata Turniak-Kusy
MSMaciej Studzian
Maciej Studzian
PSPiotr Szpakowski
Piotr Szpakowski
PKPiotr Kuchta
Piotr Kuchta
KSKaja Smietanka
Kaja Smietanka
BBBartosz Bielecki
Bartosz Bielecki
Astrocytes play an important role in the regulation of the inflammatory response in the CNS, e.g., in demyelinating diseases. Since the chemokine CXCL1 is known to be secreted by astrocytes and to have a pro-inflammatory effect on immune cells in the CNS, we verified the effect of testosterone on its secretion in vitro (in the astrocytic cell line DI TNC1). Testosterone reduced the increase in CXCL1 production caused by the pro-inflammatory agent lysophosphatidylcholine and restored the basal production level of CXCL1. The androgen receptor (present and functional in the studied cell line) was strongly suggested to mediate this effect—its non-steroid ligand flutamide exerted an agonist-like effect, mimicking the activity of testosterone itself on CXCL1 secretion. This novel mechanism has important implications for the known immunomodulatory effect of testosterone and potentially other androgenic hormones. It provides a potential explanation on the molecular level and shows that astrocytes are important players in inflammatory homeostasis in the CNS and its hormonal regulation. Therefore, it suggests new directions for the development of the therapeutic intervention.

1 September 2019 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
AWAgata Walczak
Agata Walczak
IKIwona Kurkowska-Jastrzebska
Iwona Kurkowska-Jastrzebska
BZBeata Zakrzewska-Pniewska
Beata Zakrzewska-Pniewska
MDMałgorzata W Dorobek
Małgorzata W Dorobek
WBWaldemar Brola
Waldemar Brola
ASAdam Stepien
Adam Stepien

29 May 2023 in Aktualności Neurologiczne
Verified
Journal Article
Closed access
UMUniwersytecki Szpital Kliniczny Im. Wojskowej Akademii Medycznej – Centralny Szpital Weteranów W Łodzi Klinika Neurologii i Udarów Mózgu
Uniwersytecki Szpital Kliniczny Im. Wojskowej Akademii Medycznej – Centralny Szpital Weteranów W Łodzi Klinika Neurologii i Udarów Mózgu
BLBarbara Anna Lewandowska
Barbara Anna Lewandowska
BBBartosz Bielecki
Bartosz Bielecki
UNUniwersytecki Szpital Kliniczny Nr 1 Im. N. Barlickiego W Łodzi Klinika Neurologii
Uniwersytecki Szpital Kliniczny Nr 1 Im. N. Barlickiego W Łodzi Klinika Neurologii
Biological differences associated with sexual dimorphism have an impact on many aspects of health, including disease susceptibility, course and prognosis. Significant differences in the incidence and severity of neurological diseases, especially those of autoimmune origin, were found between women and men. Although the reasons for the observed discrepancies are complex, research indicates the key role of sex hormones, which are known to be responsible for the differences in body structure, genitals and sexual behaviour in women and men. Recent data have drawn attention to their impact on the function of the immune and nervous systems, the brain and the spinal cord in particular. Multiple sclerosis is a chronic disease of the central nervous system that affects more than twice as many women as men. The etiopathogenesis of the disease is complex, with genetic and environmental factors playing an important role. There are three main components in the pathology of multiple sclerosis: inflammation, demyelination and neurodegeneration. Studies conducted so far have shown a significant influence of sex hormones, both male and female, on each of these elements. It has been shown in both clinical and experimental studies that sex hormones have not only a strong immunomodulatory, but also neuroprotective and neuroregenerative effect. Recent research on the role of sex hormones in multiple sclerosis has led to a better understanding of the mechanisms underlying the development of this disorder. They also gave hope for the introduction of sex hormones as diagnostic tools, i.e. biomarkers of progression and response to treatment, but above all, as breakthrough therapies.

Verified
Journal Article
Open access
PDF file
IJIzabela Jatczak‐Pawlik
Izabela Jatczak‐Pawlik
APAlicja Ewiak Paszynska
Alicja Ewiak Paszynska
MDMalgorzata Domowicz
Malgorzata Domowicz
BBBartosz Bielecki
Bartosz Bielecki
MŚMariola Świderek-Matysiak
Mariola Świderek-Matysiak
AJAnna Jurewicz
Anna Jurewicz
This study investigated the expression and subcellular localization of chitinase-3-like protein 1 (CHI3L1) in neutrophils and plasma from untreated and dimethyl fumarate (DMF)-treated multiple sclerosis (MS) patients, and healthy controls. Intracellular CHI3L1 expression was assessed in CD66b+ neutrophils and CD16+ cells using flow cytometry. Subcellular localization was analyzed by confocal microscopy using markers for various neutrophil granules, while ELISA measured plasma CHI3L1 and lactoferrin levels. We found that both intracellular CHI3L1 levels (expressed as mean fluorescence intensity, MFI) and the proportion of CD66b+ cells were significantly increased in MS patients compared to healthy controls. CHI3L1 was found to colocalize with CD66b+ specific granules. While plasma CHI3L1 levels in untreated MS patients remained comparable to those of healthy controls, a significant increase in both intracellular and plasma CHI3L1 was observed in DMF-treated MS patients. The lack of correlation between plasma lactoferrin and CHI3L1 might suggest selective release mechanisms or differential synthesis of these proteins, despite their common storage in specific granules. These findings highlight the role of neutrophils as a peripheral source of CHI3L1 and suggest a complex association between neutrophil-derived CHI3L1 and the differences observed in DMF-treated MS patients.